Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (181-190 of 294) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prognosis at presentation of small cell carcinoma of the lungS G Allan, M E Stewart, S Love, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trialJ F Smyth, A Bowman, T Perren, et al.
British Journal of Haematology|September 1, 1981
Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycinN H Russell, H G Prentice, N Lee, et al.
Biochemical Pharmacology|May 7, 2002
Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidationJeffrey Cummings, Gary Boyd, Brian T Ethell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lungR E Taylor, I E Smith, H T Ford, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingS G Allan, M A Cornbleet, S P Lockhart, et al.
Acta Neuropsychologica : the Official Journal of the Polish Neuropsychological Society|January 31, 2014
Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR)Chiadi U Onyike, Kelly L Sloane, Shawn F Smyth, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Interferons in oncology: current status and future directionsJ F Smyth, F R Balkwill, F Cavalli, et al.
Pageof 30

Showing results (181-190 of 294) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prognosis at presentation of small cell carcinoma of the lungS G Allan, M E Stewart, S Love, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trialJ F Smyth, A Bowman, T Perren, et al.
British Journal of Haematology|September 1, 1981
Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycinN H Russell, H G Prentice, N Lee, et al.
Biochemical Pharmacology|May 7, 2002
Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidationJeffrey Cummings, Gary Boyd, Brian T Ethell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lungR E Taylor, I E Smith, H T Ford, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingS G Allan, M A Cornbleet, S P Lockhart, et al.
Acta Neuropsychologica : the Official Journal of the Polish Neuropsychological Society|January 31, 2014
Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR)Chiadi U Onyike, Kelly L Sloane, Shawn F Smyth, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Interferons in oncology: current status and future directionsJ F Smyth, F R Balkwill, F Cavalli, et al.
Pageof 30